Guirakhoo Farshad 4
4 · Vaxxinity, Inc. · Filed May 5, 2022
Insider Transaction Report
Form 4
Vaxxinity, Inc.VAXX
Guirakhoo Farshad
Chief Scientific Officer
Transactions
- Exercise/Conversion
Class A common stock
2022-05-03$0.57/sh+10,000$5,700→ 10,000 total - Exercise/Conversion
Stock Option (right to buy)
2022-05-03−10,000→ 116,730 totalExercise: $0.57Exp: 2031-03-01→ Class A common stock (10,000 underlying)
Holdings
- 41,958
Stock Option (right to buy)
Exercise: $13.00Exp: 2031-11-11→ Class A common stock (41,958 underlying)
Footnotes (2)
- [F1]These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period.
- [F2]These options are subject to a four-year time-vesting schedule, with 25% vesting on 11/11/2022 and the remainder vesting in equal installments each month during the remainder of the vesting period.